There were 2,409 press releases posted in the last 24 hours and 441,447 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Forty Seven, Inc. Granted Fast Track Designation for Magrolimab (5F9) for the Treatment of Myelodysplastic Syndrome and Acute Myeloid Leukemia

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image